SMMT - Summit Therapeutics plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5187.01M
Enterprise Value 3120.46M
Trailing P/E N/A
Forward P/E 1-12.71
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)5.53
Price/Book (mrq)7.62
Enterprise Value/Revenue 33.57
Enterprise Value/EBITDA 6-9.02

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2017
Most Recent Quarter (mrq)Oct 31, 2017

Profitability

Profit Margin -2.22%
Operating Margin (ttm)-40.00%

Management Effectiveness

Return on Assets (ttm)-13.17%
Return on Equity (ttm)-6.25%

Income Statement

Revenue (ttm)33.79M
Revenue Per Share (ttm)2.68
Quarterly Revenue Growth (yoy)199.80%
Gross Profit (ttm)2.99M
EBITDA -13.36M
Net Income Avi to Common (ttm)-751.76k
Diluted EPS (ttm)-0.06
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.53M
Total Cash Per Share (mrq)3.15
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.07
Book Value Per Share (mrq)1.60

Cash Flow Statement

Operating Cash Flow (ttm)-20.56M
Levered Free Cash Flow (ttm)-16.92M

Trading Information

Stock Price History

Beta N/A
52-Week Change 3-4.50%
S&P500 52-Week Change 314.10%
52 Week High 316.86
52 Week Low 38.80
50-Day Moving Average 312.24
200-Day Moving Average 311.95

Share Statistics

Avg Vol (3 month) 374.4k
Avg Vol (10 day) 341.8k
Shares Outstanding 561.84M
Float 9.44M
% Held by Insiders 12.72%
% Held by Institutions 128.50%
Shares Short 33.28k
Short Ratio 30.06
Short % of Float 30.00%
Shares Short (prior month) 39.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A